After Pfizer and other companies received the cooperation agreement from Changtian Technology, they immediately started the construction of the intensive care center.
The three intensive care centers are all located in the core areas of key cities in the United States, with a very wide population coverage. Of course, the land price is also very expensive.
But it doesn't matter, for this reason the three pharmaceutical and medical companies are willing to invest a lot of money.
Because the intensive care center is an absolute monopoly business.
As long as the construction is successful, the money printing machine will be started.
And Pfizer is unwilling to delay even a second.
A second of delay can cost a lot of money.
So Pfizer took a very smart approach.
He immediately converted a private hospital in New York City, which he controlled, into an intensive care center, and immediately chartered a special plane to Changzezhou Airport, and sent the equipment and instruments needed for the intensive care center to the hospital.
At the same time, it also communicated with Changtian Technology and invited the expert team of Changtian Technology Biomedical Laboratory to New York to start work in advance.
Pfizer's idea is that after converting a private hospital into an intensive care center, it can be put into use immediately.
Then both sides are carried out simultaneously, and the real intensive care center is also under construction simultaneously.
After the intensive care center in the city center is completed, the treatment equipment and medical staff of the private hospital will be moved to the newly built intensive care center.
It neither delays making money nor delays the construction of the hospital.
As for the existing patients or medical staff in private hospitals, what should we do?
Of course, patients are transferred to other places, so Pfizer can afford a little fee.
As for the medical staff of private hospitals, those who can work in the intensive care center will go to work, and those with limited ability and unable to do the relevant work will be expelled.
Perhaps the greatest benefit is the goal that capital companies have been pursuing.
Regarding the operating principles of the US intensive care center, Changtian Technology also has its own plan.
In fact, to put it simply, there are only two in principle.
The first one is to earn as much profit as possible.
The second is to expand the influence of Changtian Technology in the U.S. market as much as possible, and lay a solid foundation for other products of Changtian Technology to enter the U.S. market in the future.
Therefore, Changtian Technology basically turned a blind eye to Pfizer's series of actions.
Late September 2015.
The first batch of 10 medical staff from Changzezhou Intensive Care Center who went to work in the United States boarded a special plane chartered by Pfizer.
Leading the team was Xu En, a young doctor from the intensive care center.
Xu En is only 33 years old this year. After graduating from Changtian Technology's natural science graduate school, he entered the Intensive Care Center for internship.
In the end, because of the excellent performance of the students, they stayed in the intensive care center and became an attending doctor and the chief surgeon of the operating room.
This trip to the United States is mainly to assist the opening and operation of the China Securities Manufacturing Center in New York.
According to the arrangement of Changtian Technology Intensive Care Center, Xu En and his team will stay in New York for about two years.
Of course, their salaries are also very high.
?I get about 200,000 RMB per month, of which 100,000 is my salary from Changtian Technology itself.
The remaining 100,000 is a subsidy from Pfizer to Changtian Technology, and Changtian Technology will distribute all subsidies to medical staff.
Xu En, like other members of his team, is full of ambition for this trip.
On the one hand, the treatment is really good. After this and that, I can earn more than 2 million a year, and the mid-year bonus is not counted.
More than 2 million yuan a year. In Xiaguo in 2015, except for those business owners and the management of large companies, it was difficult for other wage earners to get it.
Working in Changtian Technology, with this extremely high salary, Xu En from the rural areas of Northwest China can also buy a house near Changzezhou, settle down his wife and children, and feel at ease work.
On the other hand, going to New York can realize one's own life value.
Xu En and his team are the first batch of doctors in the history of Xia Guo to go to the United States for medical assistance.
As the most powerful country in the world and the country with the most advanced science and technology, the United States has always been the one who helps others, and no one else will help it at all.
And Xia Guo as"
"We request that Xia Guo's national flag and the logo of Changtian Technology Intensive Treatment Center be hung in the most conspicuous position of the hospital."
Xu En's request was not harsh, but a routine one.
In the face of absolute strength, don't talk about any feelings, this is the rule.
When the medical technology in the United States was the most developed in the past, they went to Xiaguo to guide the work as if God gave candy to the world.
Their requirements for Xiaguo Hospital are also that they must use English in all work processes and use the technical standards of the United States.
So today is just an exchange of roles, there is no one who does not pity anyone.
After Xu En made this request, the complexion of the leaders of the hospital changed instantly.
After all, the flag of the hospital represents the history of the hospital, and this flag has been erected here for more than 100 years.
But there is no way, the hospital was acquired by Pfizer, and Changtian Technology and Pfizer must withdraw if they request it.
It took another whole week for the hospital to rectify all the details in place, and only then did it begin to open to the public.
Due to the urgent time for Pfizer to build the intensive care center, the appointment mechanism for patients in the intensive care center in the United States has not yet been perfected.
Therefore, on the first day of the opening of the intensive care center, the method adopted is to make an on-site registration appointment.
Representatives of Xu En and Pfizer expected that many patients would come to make appointments on the first day of opening.
But what they didn't expect was that there were too many people.
The hospital started registration at 7:30 in the morning, and before 6 o'clock, many people came to the hospital's registration window one after another and began to line up.
Until the door opened at 7:30, the people in line had already lined up outside the hospital and circled the hospital several times.
After a rough estimate, the number of people in line should exceed 3,000.
Unlike before going to Changtian Technology Xiaguo Intensive Care Center or other overseas intensive care centers, the American patients admitted to Xiaguo Intensive Care Center and Overseas Intensive Care Center are all American elites.
They have money, rights and connections, and they can go overseas for treatment.
Most of the patients in the United States, those who are middle class and above but do not reach the elite class, they don’t have much money, and they don’t have the means to go overseas for treatment. The elite class, so you can't get the number of the intensive care center at all.
And this time, the queue is basically the middle class of the United States.
They were able to afford treatment, but had no access before.
And this time Changtian Technology gave them a way to heal.
As long as you can queue up early, you will have a chance to get a number.
When Xu En came to the hospital and saw this scene, he was deeply moved.
Medical and health problems are a big problem in every country.
In many tertiary hospitals in Xiaguo, many patients also started queuing up in the first few days after coming to the hospital for the purpose of being able to get a specialist account.
Xu En shook his head, returned to the office, and started his day's work.
While queuing up, Levi's, the New York Times reporter, and his colleagues also arrived here at 8:00, preparing for the interview.
Seeing the long crowd and those ordinary people who were exhausted in the team, Levi's heart was greatly touched.
Levi's is a columnist for the "New York Times". In the past, his reports were biased as long as the topic of Xia Guo was involved.
This is a common concept formed by Western public opinion circles for a long time.
As long as you report Xia Guo well, you will be abandoned by the entire public opinion circle, and even criticized by many colleagues.
But as long as you report the bad news of Xia Guo, and describe it vividly, then you will not only gain traffic, but also gain fame.
Levi's is such a person.
But seeing this scene at the scene today, Levi couldn't help but said to the camera: "The number of people queuing up at the scene should be more than 3,000 people, and many people came from Chicago, Florida and other places at any time and arrived a few days in advance. here."
"These patients tell us that Americans also need Changtian Technology's intensive care center very much. This is not about political and economic disputes, but the lives of ordinary people."
Levi's said with a long sigh: "I hope that those who line up here can get what they want, get active treatment, and recover."
During the entire reporting process, Levi's never said a word "good" about Changtian Technology or Xia Guo from the beginning to the end.
He didn't say it because he is American, this is his professional ethics.
But even so, he has revealed in his words the true thoughts of most Americans-life and health are above all else.?
During the entire reporting process, Levi's never said a word "good" about Changtian Technology or Xia Guo from the beginning to the end.
He didn't say it because he is American, this is his professional ethics.
But even so, he has revealed the true thoughts of most Americans in his words-life and health are above all else.